ESAR - European Surveillance of Antibiotic Resistance
All Alert isolates
Alert Organisms by phenotype, Total and Percent resistant

Year = 2000
  All centers Aberdeen Leipzig Bratislava (St. El.) Bratislava (NCI) Warsaw
Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant
N % N % N % N % N % N %
Organism Phenotype 5353 169 3.16 3217 57 1.77 576 5 0.87 172 18 10.47 1268 86 6.78 120 3 2.50
Beta-haemolytic Streptococci Macrolide
Glycopeptide 5353 0 0.00 3217 0 0.00 576 0 0.00 172 0 0.00 1268 0 0.00 120 0 0.00
Penicillin 5353 2 0.04 3217 1 0.03 576 1 0.17 172 0 0.00 1268 0 0.00 120 0 0.00
Pneumococci Macrolide 2599 166 6.39 584 23 3.94 120 2 1.67 19 2 10.53 1773 137 7.73 103 2 1.94
Glycopeptide 2599 0 0.00 584 0 0.00 120 0 0.00 19 0 0.00 1773 0 0.00 103 0 0.00
High level Penicllin 2599 1 0.04 584 0 0.00 120 0 0.00 19 0 0.00 1773 1 0.06 103 0 0.00
Low level Penicillin 2599 245 9.43 584 7 1.20 120 0 0.00 19 2 10.53 1773 236 13.31 103 0 0.00
Enterococci Beta-lactamase positive 11498 163 1.42 4933 0 0.00 1925 42 2.18 189 11 5.82 3621 110 3.04 830 0 0.00
Glycopeptide 11498 12 0.10 4933 1 0.02 1925 8 0.42 189 0 0.00 3621 1 0.03 830 2 0.24
High level aminoglycoside 11498 584 5.08 4933 0 0.00 1925 334 17.35 189 10 5.29 3621 133 3.67 830 107 12.89
Haemophilus Beta-lactamase positive 5486 275 5.01 934 60 6.42 296 0 0.00 86 5 5.81 3768 208 5.52 402 2 0.50
Ceftazidime/3rd or 4th generation cephalosporin 5486 0 0.00 934 0 0.00 296 0 0.00 86 0 0.00 3768 0 0.00 402 0 0.00
Ciprofloxacin/4-fluoroquinolone 5486 0 0.00 934 0 0.00 296 0 0.00 86 0 0.00 3768 0 0.00 402 0 0.00
Enterobacteriaceae Carbapenem 44693 13 0.03 23381 2 0.01 4126 2 0.05 785 0 0.00 14378 9 0.06 2023 0 0.00
Ciprofloxacin/4-fluoroquinolone 44693 1356 3.03 23381 438 1.87 4126 208 5.04 785 33 4.20 14378 573 3.99 2023 104 5.14
Extended spectrum beta-lactamase positive 44693 302 0.68 23381 2 0.01 4126 114 2.76 785 18 2.29 14378 137 0.95 2023 31 1.53
Gentamicin 44693 1047 2.34 23381 112 0.48 4126 141 3.42 785 28 3.57 14378 571 3.97 2023 195 9.64
Acinetobacter Carbapenem 2788 13 0.47 880 0 0.00 258 1 0.39 45 2 4.44 1150 8 0.70 455 2 0.44
Gentamicin 2788 522 18.72 880 0 0.00 258 6 2.33 45 17 37.78 1150 404 35.13 455 95 20.88
Staphylococcus aureaus Total Methicillin 25359 1225 4.83 11207 955 8.52 2049 47 2.29 207 4 1.93 9780 189 1.93 2116 30 1.42
Teicoplanin 25359 0 0.00 11207 0 0.00 2049 0 0.00 207 0 0.00 9780 0 0.00 2116 0 0.00
Vancomycin 25359 0 0.00 11207 0 0.00 2049 0 0.00 207 0 0.00 9780 0 0.00 2116 0 0.00
Cholera Tetracycline/Doxycycline 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 -
Trimethoprim 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 -
Campylobacter Ciprofloxacin 2262 84 3.71 2148 84 3.91 10 0 0.00 0 0 - 96 0 0.00 8 0 0.00
Shigella Ciprofloxacin 409 0 0.00 19 0 0.00 4 0 0.00 0 0 - 386 0 0.00 0 0 -
Salmonella Ciprofloxacin 1930 2 0.10 496 2 0.40 45 0 0.00 3 0 0.00 1386 0 0.00 0 0 -
Neisseria meningitidis Penicillin 61 1 1.64 55 1 1.82 0 0 - 0 0 - 6 0 0.00 0 0 -
Neisseria gonorrhoea Beta-lactamase positive 119 8 6.72 114 5 4.39 0 0 - 0 0 - 5 3 60.00 0 0 -
Ciprofloxacin/4-fluoroquinolone 119 8 6.72 114 8 7.02 0 0 - 0 0 - 5 0 0.00 0 0 -
Anaerobes Augmentin/beta-lactamase inhibitor combination 5024 8 0.16 3807 8 0.21 511 0 0.00 28 0 0.00 678 0 0.00 0 0 -
Carbapenem 5024 0 0.00 3807 0 0.00 511 0 0.00 28 0 0.00 678 0 0.00 0 0 -
Metronidazole 5024 9 0.18 3807 0 0.00 511 0 0.00 28 8 28.57 678 1 0.15 0 0 -
Coagulase negative Staphylococci Teicoplanin 17598 2 0.01 13320 1 0.01 1404 1 0.07 73 0 0.00 2801 0 0.00 0 0 -
Vancomycin 17598 0 0.00 13320 0 0.00 1404 0 0.00 73 0 0.00 2801 0 0.00 0 0 -
Pseudomonas aeruginosa Ceftazidime/4th generation cephalosporin 9862 289 2.93 5379 27 0.50 872 29 3.33 146 12 8.22 2733 179 6.55 732 42 5.74
Gentamicin 9862 1067 10.82 5379 17 0.32 872 85 9.75 146 34 23.29 2733 840 30.74 732 91 12.43
Piperacillin/Tazobactam 9862 291 2.95 5379 28 0.52 872 44 5.05 146 3 2.05 2733 189 6.92 732 27 3.69

ESBiC Study Center